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Introduction
This article presents an overview of solid organ trans-
plantation in the United States and is produced as part
of the 2008 OPTN/SRTR Annual Report. The Annual Re-
port is prepared by the Scientific Registry of Transplant
Recipients (SRTR) in collaboration with the Organ Pro-
curement and Transplantation Network (OPTN) under con-
tract with the Health Resources and Services Adminis-
tration (HRSA). The report reviews many aspects of solid
organ transplantation and is a valuable resource for pa-
tients, the transplant community, the public and the federal
government.
This report includes eight articles focused on specific top-
ics in solid organ transplantation. Each article was writ-
ten by experts in the field of transplantation and provides
a comprehensive look at the current state of transplan-
tation and trends over the past 10 years. The text and
figures in these articles are drawn from recent SRTR anal-
yses and the extensive reference tables of the 2008 An-
nual Report. This report was prepared by the Arbor Re-
search Collaborative for Health, which, with the University
of Michigan, has been the contractor for the SRTR since
October 2000. These eight articles and the 2008 Annual
Report reference tables are available online, at the web-
sites of the SRTR and OPTN (www.ustransplant.org and
www.optn.org).
Summary Statistics on Organ
Transplantation in the United States
At the close of 2006 there were 173 339 persons recorded
in available OPTN data, who were living with a functioning
organ transplant [Table 1.14]. This number reflects an in-
crease of 1.6% over 2005 and a 60% increase since 1998.
The total number of organs transplanted decreased from
28 291 in 2006 to 27 578 in 2007; this was an overall de-
crease of 713 organs transplanted (2.5%) and a decrease
of 423 (6.3%) in living donor transplants (Table 1). De-
ceased donor kidney transplants decreased by 1.3%, and
living donor kidney transplants dropped by 6.1%. A de-
crease of 3.8% was observed in deceased donor liver
transplants in 2007.
The number of lung transplants increased 4.3% while
heart, deceased donor intestine, pancreas and heart–lung
transplantation changed little. The 27 578 organs trans-
planted in 2007 came from 14 399 organ donors, 357
fewer donors than there were in 2006 (2.4% decrease)
[Table 1.1].
The total number of transplants in the United States in-
creased on average by 872 transplants per year between
1998 and 2006 [Table 1.7]. Thus, the decrease of 713 trans-
plants in 2007 represents a substantial divergence from the
longstanding trend. This drop was largely due to decreases
in donation, particularly by living donors. There were 423
(6.3%) fewer living donors in 2007 than in 2006. Living
donation has been decreasing since 2004 [Table 1.1].
The number of organs recovered for transplant from de-
ceased donors has similarly departed from the recent
trend. In 2007, there were 28 409 organs recovered com-
pared with 28 322 in 2006 (Table 2). This increase of 87
organs is the smallest in 10 years. An average increase of
930 organs per year was seen between 1998 and 2006
[Table 1.2].
More multiorgan transplants (97) were performed in 2007
than in 2006, the biggest increase in the number of multior-
gan transplants in 10 years. Those 97 transplants involved
229 total organs [Table 1.8].
The percentage of kidneys recovered but not used for
transplant was the highest in 10 years. In 2007, there were
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Table 1: Change in number of transplanted organs, 2006–2007
Transplanted organs 2006 2007 Percent change
Total 28 291 27 578 −2.5
Deceased donor 21 562 21 272 −1.3
Living donor 6729 6306 −6.3
Kidney 16 644 16 119 −3.2
Deceased donor 10 212 10 082 −1.3
Living donor 6432 6037 −6.1
Pancreas 1368 1304 −4.7
PTA 98 110 12.2
PAK 292 259 −11.3
Kidney–pancreas 914 848 −7.2
Liver 6136 5890 −4.0
Deceased donor 5849 5625 −3.8
Living donor 287 265 −7.7
Intestine 60 57 −5.0
Deceased donor 57 57 0.0
Living donor 3 − n/a
Heart 2148 2141 −0.3
Deceased donor 2147 2141 −0.3
Living donor 1 − n/a
Lung 1401 1461 4.3
Deceased donor 1397 1458 4.4
Living donor 4 3 −25.0
Heart–lung 31 29 −6.5
Source: 2008 OPTN/SRTR Annual Report, Table 1.7.
Table 2: Growth in number of recovered organs, 2006–2007
Recovered organs 2006 2007 Percent change
Total 28 322 28 409 0.31
Kidney 14 284 14 384 0.70
Pancreas–all 2032 1927 −5.17
Liver 7084 7029 −0.78
Intestine 185 205 10.81
Heart 2276 2289 0.57
Lung 2461 2575 4.63
Source: 2008 OPTN/SRTR Annual Report, Table 1.2.
Table 3: Patients on waiting lists, 2006–2007
End of year
Organs 2006 2007 Percent change
Total 92 845 97 248 4.7
Kidney 66 352 71 862 8.3
PTA 598 585 −2.2
PAK 988 918 −7.1
Kidney–pancreas 2326 2242 −3.6
Liver 16 623 16 438 −1.1
Intestine 234 222 −5.1
Heart 2769 2659 −4.0
Lung 2822 2217 −21.4
Heart–lung 133 105 −21.1
Source: 2008 OPTN/SRTR Annual Report, Table 1.3. PTA =
pancreas transplant alone; PAK = pancreas after kidney.
Table 4: Unadjusted 1- and 5-year patient survival by organ
Organ One-year Five-year
transplanted survival (%) survival (%)
Kidney
Deceased donor 95.0 81.0
Living donor 98.2 90.6
Pancreas alone 97.9 88.7
Pancreas after kidney 97.3 83.9
Kidney–pancreas 95.1 86.6
Liver
Deceased donor 87.1 73.3





Source: 2008 OPTN/SRTR Annual Report, Table 1.13.
2389 kidneys (16.6% of kidneys recovered that year) that
were discarded compared with the 2129 (14.9%) kidneys
discarded in 2006 [Table 3.1].
At the end of 2007, there were 97 248 people registered
on organ waiting lists (65 411 active, 31 821 inactive and 16
of unknown status); this reflects a 4.7% increase over the
number of people waiting for an organ at the end of 2006
[Table 1.4]. The percentage of patients who were inactive
on the kidney waiting list at the end of each year has in-
creased from 15% to 32% from 2003 to 2007, with 23 089
patients listed as inactive status in 2007 [Tables 5.1a and
b]. This increase is presumably due to policy implemented
in 2003 that allows accrual of waiting time during inactive
status.
Table 3 shows the 1-year change in the number of patients
on the waiting list for each organ and includes patients
listed at both active and inactive status. The kidney wait-
ing list grew by 8.3% while the list for kidney–pancreas
Table 5: Unadjusted 1- and 5-year graft survival by organ
Organ One-year Five-year
transplanted survival (%) survival (%)
Kidney
Deceased donor 90.4 68.2
Living donor 95.6 80.7
Pancreas alone 81.2 51.3
Pancreas after kidney 77.2 53.6
Kidney–pancreas (kidney) 92.8 78.5
Kidney–pancreas (pancreas) 86.0 72.6
Liver
Deceased donor 82.4 67.6





Source: 2008 OPTN/SRTR Annual Report, Table 1.13.
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Figure 1: Kidney transplantation
at a glance. (A) Number of trans-
plants and size of active waiting
list: There was a very large gap be-
tween the number of patients wait-
ing for a transplant and the num-
ber receiving a transplant. This gap
widened over the decade, meaning
that the waiting times from listing to
transplant continued to increase. The
number of living donor transplants
grew until 2004, while the num-
ber of deceased donor transplants
continued to rise gradually. Source:
2008 OPTN/SRTR Annual Report,
Tables 1.7, 5.1a. (B) Age distribu-
tion of recipients and active waiting
list: In 2007, older candidates (age >
50 years) made up a much larger
fraction of patients actively awaiting
an organ than a decade earlier. The
same pattern was observed for trans-
plant recipients, except that young
patients (age < 35 years) showed
a greater representation among re-
cipients than on the waiting list.
Source: 2008 OPTN/SRTR Annual
Report, Tables 5.1a, 5.4a, 5.4b, 5.4c.
(C) Unadjusted patient and graft sur-
vival: Five-year patient survival per-
centages (based on transplants dur-
ing 2001–2006) and 10-year patient
survival (based on transplants dur-
ing 1996–2006) were clearly higher
for recipients of living donor organs
than for those of deceased donor or-
gans. Similarly, living donor organs
had the highest 5- and 10-year graft
survival. Source: 2008 OPTN/SRTR
Annual Report, Tables 5.10a, 5.10b,
5.10d, 5.14a, 5.14b, 5.14d.
shrank by 3.6%. Other modest declines were seen on the
liver and heart lists; the largest decline (21.4%) was seen
on the lung waiting list. Dramatic changes regarding the
lung waiting list in 2005 and 2006 might be largely caused
by changes in the deceased donor lung allocation policy
that were implemented in May 2005. Changes in the soli-
tary pancreas (pancreas transplant alone; PTA), pancreas
after kidney (PAK), intestine and heart–lung waiting lists all
reflect relatively small numbers of patients.
Patient survival after transplant is an important metric for
evaluating the success of transplantation. Table 4 shows
the percentage of transplant recipients still alive 1 and
5 years after transplantation, by organ. The cohort used
to compute 1-year survival consists of recipients trans-
planted in 2005–2006, while the cohort for 5-year survival
is based on recipients transplanted in 2001–2006. These
are the most recent cohorts for which adequate follow-up
data have been collected. Kidney recipients and pancreas
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Figure 2: Pancreas transplantation
alone (PTA) at a glance. (A) Num-
ber of transplants and size of active
waiting list: The number of patients
on the waiting list for a pancreas
transplant alone had been decreasing
since 2003, but it rose slightly in 2006
and 2007. The number of PTA trans-
plants per year was relatively stable.
Source: 2008 OPTN/SRTR Annual Re-
port, Tables 1.7, 6.1a. (B) Age distri-
bution of recipients and active waiting
list: For PTA, more pediatric candi-
dates were wait-listed and more re-
ceived a transplant in 2007 than in
1998, although the absolute num-
bers are small. At the same time,
the fraction of recipients over age 50
years grew. Pediatric diabetic patients
rarely have kidney failure before age
18 years, but they are candidates
for PTA. Source: 2008 OPTN/SRTR
Annual Report, Tables 6.1a, 6.4. (C)
Unadjusted patient and graft sur-
vival: For PTA transplants, patient sur-
vival has been excellent. The 5-year
patient survival rate was 89%. Graft
survival was considerably lower, es-
pecially at 5 and 10 years post-
transplant. Source: 2008 OPTN/SRTR
Annual Report, Tables 6.10, 6.14.
recipients had the highest 1-year patient survival rates,
ranging from about 95% to 98%. One-year survival for liver,
intestine, lung and heart recipients was approximately 81–
90%. Survival was lowest for the small number of heart–
lung recipients: approximately 74% survived 1 year.
Table 5 shows graft survival by organ, that is, the percent-
age of transplanted organs that were still functioning 1
and 5 years after transplantation. Graft survival was calcu-
lated using the same cohorts as patient survival (Table 4);
these groups represent the most recent cohorts available
with adequate follow-up data. Over 90% of kidneys trans-
planted alone or as part of a kidney–pancreas transplant
were functioning 1 year after transplantation. Graft survival
rates were lower than corresponding patient survival rates
because some patients survived organ failure by receiving
872 American Journal of Transplantation 2009; 9 (Part 2): 869–878
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Figure 3: Pancreas after kidney
(PAK) transplantation at a glance.
(A) Number of transplants and size
of active waiting list: As with PTA,
the number of patients on the wait-
ing list for a PAK transplant has
decreased since 2003. The num-
ber who received a transplant has
matched the number of candidates
each year since 2004. The number
of PAK transplants has decreased
from its highest level of the decade
in 2004. Source: 2008 OPTN/SRTR
Annual Report, Tables 1.7, 7.1a. (B)
Age distribution of recipients and ac-
tive waiting list: For PAK, a higher
proportion of wait-listed and trans-
planted patients were over 50 years
old in 2007 than in 1998. At the same,
time, a smaller proportion of can-
didates and recipients were in the
18-34 year age group. (Since recip-
ients were mostly type 1 diabetics,
the ages below 18 and above 65
years were virtually unrepresented.)
Source: 2008 OPTN/SRTR Annual
Report, Tables 7.1a, 7.4. (C) Unad-
justed patient and graft survival: For
PAK transplants, patient survival was
similar to that seen for simultane-
ous kidney-pancreas transplant recip-
ients. Five-year patient survival was
84%. Pancreas graft survival after
PAK was considerably lower. Source:
2008 OPTN/SRTR Annual Report,
Tables 7.10, 7.14.
a subsequent transplant or alternative therapy such as dial-
ysis or insulin therapy.
Transplantation at a Glance
The figure sets accompanying this article (Figures 1–8)
provide overviews of the state of transplantation for dif-
ferent organs. These summary graphics are included for
six organs: kidney, pancreas (as PTA or PAK transplant,
liver, intestine, heart and lung), as well as the most com-
mon multiorgan procedure, simultaneous pancreas–kidney
transplantation. Other multiorgan procedures are excluded
from the counts presented here (e.g. heart–lung trans-
plants) because of the small numbers of these procedures.
Below we describe the three types of graph shown for each
organ.
Number of transplants and size of active waiting list
These figures compare, for each of the past 10 years, the
size of the active waiting list and the number of transplants
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Figure 4: Simultaneous pancreas–
kidney (SPK) transplantation at a
glance. (A) Number of transplants
and size of active waiting list: SPK ac-
counts for the majority of all pancreas
transplants. Numbers of this proce-
dure were stable over the decade.
The gap between the number of pa-
tients waiting for a transplant and the
number receiving a transplant has
dropped substantially since 2000.
Source: 2008 OPTN/SRTR Annual
Report, Tables 1.7, 8.1a. (B) Age dis-
tribution of recipients and active wait-
ing list: For SPK transplantation, pa-
tients over age 50 years made up
greater fractions of both candidates
and recipients in 2007 than in 1998.
At the same time, smaller propor-
tions of candidates and recipients
were in the 18–34 year age group.
(Since recipients were mostly type
1 diabetics, the ages below 18 and
above 65 years were virtually unrep-
resented.) Source: 2008 OPTN/SRTR
Annual Report, Tables 8.1a, 8.4. (C)
Unadjusted patient and graft sur-
vival: Patient survival has improved
for SPK recipients in recent years.
Five- and 10-year patient survival
was 87% and 70%, respectively.
Graft survival is shown separately for
the pancreas graft and the kidney
graft of each SPK transplant. Source:
2008 OPTN/SRTR Annual Report,
Tables 8.10, 8.14.
performed. The size of the waiting list is a snapshot of
the number of candidates active on the waiting list on
December 31 of each year, and does not count patients
who were transplanted, listed or removed during the pre-
ceding 12 months. The number of transplants includes
all transplants performed over the year. This difference in
methods of counting explains why for some organs (e.g.
lung), the number of transplants performed during a cer-
tain year may exceed the number of people awaiting a
transplant on the last day of the same year. In other cases,
changes in allocation policy and wait-listing practices help
explain the narrowing gap between waiting list size and
number of transplants.
Unadjusted patient and graft survival
These summary figures show survival of transplant recipi-
ents (patient survival) and continued function of the trans-
planted organ (graft survival) at 3 months, 1, 5 and 10 years
following transplantation. The results for each follow-up
874 American Journal of Transplantation 2009; 9 (Part 2): 869–878
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Figure 5: Liver transplantation at
a glance. (A) Number of trans-
plants and size of active waiting
list: The number of patients await-
ing a liver transplant at year-end
peaked in 2001; this is clearly re-
lated to the introduction of the
MELD/PELD allocation system in
2002. The number who received a
deceased donor liver transplant has
gradually increased, reaching a peak
in 2006. The gap between the num-
bers of candidates and recipients has
been slowly shrinking since 2002.
Source: 2008 OPTN/SRTR Annual
Report, Tables 1.7, 9.1a, 9.1b. (B)
Age distribution of recipients and
active waiting list: The numbers of
candidates and recipients age 35–49
years remained fairly constant over
the decade, but the age group’s pro-
portion by both measures declined.
Recipients included transplants from
both living and deceased donors.
Source: 2008 OPTN/SRTR Annual
Report, Tables 9.1a, 9.4a, 9.4b. (C)
Unadjusted patient and graft survival:
Patient survival in recent years has
been improving for both deceased
donors and living donors, with 73%
and 77% of patients, respectively,
alive 5 years following transplanta-
tion. Patient survival was higher than
graft survival because of the op-
portunity for repeat liver transplan-
tation in the event of graft failure.
Source: 2008 OPTN/SRTR Annual
Report, Tables 9.10a, 9.10b, 9.14a,
and 9.14b.
time are based on information about the most recent co-
horts that allow sufficient follow-up time for data collection
and ascertainment of events.
The Articles in the 2008 Report on the State
of Transplantation
The articles in this report begin with a review of trends in
organ donation and utilization (1). Following are four organ-
specific articles covering kidney and pancreas (2), liver and
intestine (3), heart (4) and lung transplantation (5); these
provide detailed trends in donation, waiting time, alloca-
tion, posttransplant outcomes and the demographics of
both candidates and recipients. Additionally, these articles
supplement the reporting of 10-year trends with updates
on recent changes in allocation policy, clinical practice and
other areas relevant to the transplantation of different or-
gan types.
This year’s report concludes with two special-focus ar-
ticles that look closely at issues of recent interest to
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Figure 6: Intestine transplantation
at a glance. (A) Number of trans-
plants and size of active waiting list:
The numbers of patients on the in-
testine waiting list and the number
receiving a transplant both more than
doubled between 1998 and 2007.
The difference between the num-
ber of candidates and transplant re-
cipients increased through the sec-
ond half of the decade. Source:
2008 OPTN/SRTR Annual Report,
Tables 1.7, 10.1a. (B) Age distribu-
tion of recipients and active wait-
ing list: About 74% of intestine can-
didates were in the pediatric age
group in 1998 compared with 81%
in 2007. The small group of can-
didates and recipients in the age
group > 50 years doubled during the
decade. Adults made up a greater
portion of recipients than candidates.
Source: 2008 OPTN/SRTR Annual
Report, Tables 10.1a, 10.4. (C) Un-
adjusted patient and graft survival:
One-year patient survival was 79%
in 2007. Survival at 5 years was 57%.
Graft survival was lower, since recip-
ients may receive parenteral alimen-
tation or retransplantation after graft
failure. Source: 2008 OPTN/SRTR
Annual Report, Tables 10.10, 10.14.
the transplant community. ‘Innovation in Outcomes As-
sessment Follow Transplantation’ (6) details the method-
ology used in recent SRTR work that focuses on pro-
viding better quality assessment and improvement tools
for transplant programs. ‘Survival Benefit-Based Deceased
Donor Liver Allocation’ (7) discusses ongoing methodolog-
ical approaches developed by the SRTR to calculate the
incremental years of life attributable to liver transplanta-
tion. This concept is central to a revision of deceased
donor liver allocation policy currently under consideration.
These articles all include special analyses conducted by
the SRTR and touch on topics that are both timely and per-
tinent because of their implications for policy and clinical
practice.
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Figure 7: Heart transplantation at
a glance. (A) Number of trans-
plants and size of active waiting
list: The number of heart transplants
has increased since 2005 follow-
ing several years of gradual reduc-
tion. The number of patients await-
ing a heart decreased steeply from
2000 to 2005, likely reflecting im-
provements in medical and surgical
therapy for end-stage heart failure.
Source: 2008 OPTN/SRTR Annual Re-
port, Tables 1.7, 11.1a. (B) Age distri-
bution of recipients and active wait-
ing list: Trends in the age distribution
of wait-listed candidates show that
the proportions (and absolute num-
bers) of patients younger than 35
and older than 64 years increased,
while the age group 35–64 years was
less represented. The trend in trans-
plant recipient age showed a similar
pattern, although the ages below
35 years had greater representation
than on the waiting list. Source:
2008 OPTN/SRTR Annual Report,
Tables 11.1a, 11.4. (C) Unadjusted pa-
tient and graft survival: Patient sur-
vival improved in recent years for
heart recipients. At 1, 5, and 10
years following heart transplantation,
88%, 74%, and 55% of patients, re-
spectively, were alive. Graft survival
was very similar to patient survival
because very few patients receive
a second heart transplant. Source:
2008 OPTN/SRTR Annual Report,
Tables 11.10, 11.14.
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